Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies

Bioorganic & Medicinal Chemistry Letters
2009.0

Abstract

Radioligands are powerful tools for examining the pharmacological profiles of chemical leads and thus facilitate drug discovery. In this study, we identified and characterized 3-([1,1,1-(3)H]methyl)-2-(4-{[3-(1-pyrrolidinyl)propyl]oxy} phenyl)-4(3H)-quinazolinone ([(3)H]1) as a potent and selective radioligand for histamine H(3) receptors. Radioligand [(3)H]1 exhibited appreciable specific signal in brain slices prepared from wild-type mice but not from histamine H(3) receptor-deficient mice, demonstrating the specificity and utility of [(3)H]1 as a selective histamine H(3) receptor radioligand for ex-vivo receptor occupancy assays.

Knowledge Graph

Similar Paper

Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies
Bioorganic & Medicinal Chemistry Letters 2009.0
Radiofluorinated histamine H3 receptor antagonist as a potential probe for in vivo PET imaging: Radiosynthesis and pharmacological evaluation
Bioorganic & Medicinal Chemistry 2012.0
Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies
European Journal of Medicinal Chemistry 2020.0
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H<sub>3</sub> Receptor
Journal of Medicinal Chemistry 2021.0
The Alkaloid Conessine and Analogues as Potent Histamine H<sub>3</sub>Receptor Antagonists
Journal of Medicinal Chemistry 2008.0
Development of a New Class of Nonimidazole Histamine H<sub>3</sub> Receptor Ligands with Combined Inhibitory Histamine N-Methyltransferase Activity
Journal of Medicinal Chemistry 2002.0
Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3′S)-2-methyl-[1,3′]bipyrrolidinyl-1′-yl)phenyl] amide as histamine H3 receptor antagonist for the treatment of depression
Bioorganic &amp; Medicinal Chemistry Letters 2013.0
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists
European Journal of Medicinal Chemistry 2009.0
[<sup>3</sup>H]UR-DEBa176: A 2,4-Diaminopyrimidine-Type Radioligand Enabling Binding Studies at the Human, Mouse, and Rat Histamine H<sub>4</sub> Receptors
Journal of Medicinal Chemistry 2019.0
Synthesis and in Vitro Pharmacology of a Series of New Chiral Histamine H<sub>3</sub>-Receptor Ligands:  2-(RandS)-Amino-3-(1H-imidazol-4(5)-yl)propyl Ether Derivatives
Journal of Medicinal Chemistry 1999.0